RegeneRx Biopharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; RegeneRx Biopharmaceuticals is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	$ 19.19K	$ 19.19K	$ 19.19K	$ 19.19K	$ 19.19K
Gross Profit	$ 19.19K	$ 19.19K	-	-	-
EBIT	$ -304.90K	$ -308.85K	$ -284.43K	$ -464.79K	$ -343.77K
EBITDA	$ -304.90K	$ -308.85K	$ -284.43K	$ -464.79K	$ -343.77K
Net Income Common Stockholders	$ -385.20K	$ -390.91K	$ -366.51K	$ -545.98K	$ -424.06K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 101.56K	$ 290.89K	$ 478.41K	$ 706.65K	$ 925.30K
Total Assets	$ 186.81K	$ 382.18K	$ 580.99K	$ 735.50K	$ 960.53K
Total Debt	$ 1.23M	$ 73.56K	$ 1.39M	$ 1.26M	$ 1.21M
Net Debt	$ 1.13M	$ -217.33K	$ 910.24K	$ 551.49K	$ 286.19K
Total Liabilities	$ 3.93M	$ 3.83M	$ 3.72M	$ 3.60M	$ 3.53M
Stockholders Equity	$ -3.74M	$ -3.45M	$ -3.14M	$ -2.86M	$ -2.57M
Cash Flow	-
Free Cash Flow	$ -189.33K	$ -187.52K	$ -228.24K	$ -218.66K	$ -306.30K
Operating Cash Flow	$ -189.33K	$ -187.52K	$ -228.24K	$ -218.66K	$ -306.30K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	$ 0.00	$ 0.00	$ 0.00

Currency in USD

RegeneRx Biopharmaceuticals Earnings and Revenue History

Income Statement >

RegeneRx Biopharmaceuticals Debt to Assets

Balance Sheet >

RegeneRx Biopharmaceuticals Cash Flow

Cash Flow >

RegeneRx Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing